Ludwig Enterprises, Inc. (LUDG)

Market Cap	5.85M -74.6%
Revenue (ttm)	n/a
Net Income	-2.24M
EPS	-0.01
Shares Out	167.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	29,547
Open	0.0350
Previous Close	0.0350
Day's Range	0.0350 - 0.0350
52-Week Range	0.0205 - 0.1279
Beta	1.83
RSI	45.39
Earnings Date	Mar 31, 2026

About Ludwig Enterprises

Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecula...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1988
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: LUDG